G

AIVI · Weight decrease · 2d

WisdomTree's AIVI, employing an AI selection method within its developed-international value-factor pool, has systematically decreased its weight in Genpact through periodic rebalances. This consistent de-emphasis, observable in the daily weight changes from 1.0059% down to 0.9404% over two weeks, suggests the AI’s model is identifying reasons to reduce exposure despite the stock’s significant price declines. With Genpact’s 90-day return sitting at -23.6%, the AI appears to be moving away from the stock, indicating it no longer fits the fund's specific value criteria. The fund's roughly 100-stock portfolio means such sustained shifts are a deliberate signal from the AI.

weight 0.975% → 0.940% (-0.034 pp)·stock down 6.2% in the 30 days before

Jul 15·entry $30.07·now $30.64

AIVI · Weight decrease · 6d

Genpact is currently trading at $30.48, which is 63% of its 52-week high of $48.50, following significant price erosion with returns of -7.5% over 30 days and -30.7% over the past year. This persistent negative price momentum likely prompted WisdomTree's AIVI, an AI-managed ETF focused on international value stocks, to initiate a series of reductions in its Genpact weighting, falling from 1.0149% on July 1st to 0.9699% by July 10th. Despite the lower share price, the AI’s selection model, operating within its developed-international value framework, presumably identified underlying shifts in G’s comparative financial characteristics or risk profile that warranted a sequential rebalancing away from the stock, even as it dipped closer to its 52-week low.

weight 1.020% → 0.970% (-0.050 pp)·stock down 10.0% in the 30 days before

Jul 10·entry $29.37·now $30.64

AIVI · Weight decrease · 5d

The weight of Genpact Ltd (G) in AIVI shows a sustained, gradual reduction from 1.0289% to 0.9768% over the period, notably decreasing daily from July 1st through July 8th. This persistent trimming of exposure suggests AIVI’s AI overlay, which selects from developed-international value stocks, is continuously reassessing G's inclusion. Despite G's current price of $29.64 representing a 29.8% decline over the last year and sitting at 61% of its 52-week high, the AI's models are likely indicating a deterioration in underlying value factors or an increased risk profile. Therefore, the manager’s AI is systematically decreasing its allocation to Genpact, even as the stock price remains significantly off its highs, diverging from a simple "buy the dip" strategy for this international value fund.

weight 1.020% → 0.977% (-0.043 pp)·stock down 10.1% in the 30 days before

Jul 8·entry $29.34·now $30.64

AIVI · Weight decrease · 4d

Genpact Ltd is trading at $29.34, hovering near its 52-week low of $27.50, and currently sits at 60% of its $48.50 52-week high. This price point follows substantial declines, including a -5.9% 30-day return and a -29.7% 1-year return. Despite these steep drops, which might suggest a value opportunity, WisdomTree's AIVI ETF, which employs AI selection within a developed-international value-factor pool, initiated a consecutive weight decrease in Genpact from 1.0149% on July 1st to 0.9791% by July 7th. This movement indicates that the AI's models are identifying diminishing value or increased risk factors in the Industrials sector company, even as its market price has fallen considerably. The AI's persistent reduction of G's allocation, despite the stock's current position near the bottom of its 52-week range, points to a lack of conviction in its value prospects relative to other international developed-market opportunities within the fund's mandate.

weight 1.020% → 0.979% (-0.041 pp)·stock down 9.5% in the 30 days before

Jul 7·entry $29.74·now $30.64

AIVI · Weight decrease · 3d

Trading at $29.74, Genpact Ltd has seen significant price depreciation, with a -29.5% one-year return and a -6.8% decline over the last 30 days, placing it at 61% of its 52-week high. Operating within WisdomTree’s developed-international value-factor pool, the AI selection process for AIVI likely flagged G’s deteriorating performance as impacting its fundamental valuation. The consecutive weight decrease in G, an Industrials sector company, from 1.0149% on July 1st to 0.9907% on July 6th, reflects this reassessment. This indicates the AI overlay determined G, despite its current lower price, no longer met the specific criteria for inclusion or weight maintenance within its approximately 100-stock portfolio, leading to a reduction in exposure.

weight 1.020% → 0.991% (-0.029 pp)·stock down 10.3% in the 30 days before

Jul 6·entry $28.96·now $30.64

AIVI · Weight decrease · 2d

Genpact's significant price depreciation, marked by a -9.4% 30-day return and currently at $29.10—60% of its 52-week high—firmly places it within AIVI's international value selection framework. Despite these pronounced value indicators, the AI manager overseeing AIVI implemented a consecutive weight decrease for Genpact, shifting its allocation from 1.0149% on July 1st to 1.0059% on July 2nd. This adjustment by the AI, managing a portfolio of approximately 100 international developed-market value stocks, occurred while Genpact was trading near its $27.50 52-week low. The AI's decision to slightly reduce exposure, even amidst such deep valuation, suggests its algorithm identified a nuanced reallocation opportunity or a relative change in attractiveness compared to other holdings within its specific value-factor pool.

weight 1.020% → 1.006% (-0.014 pp)·stock down 11.9% in the 30 days before

Jul 2·entry $29.10·now $30.64

AIVI · Weight decrease · 2d

Genpact (G) trades at $32.06, 66% of its $48.50 52-week high, following a -25.0% return over the past year and -6.6% in the last 30 days. This price context for the Industrials sector stock, situated near the lower end of its $28.94 to $48.50 52-week range, would generally align with AIVI’s international value strategy and AI selection method. However, the AI-managed ETF showed a two-day consecutive weight decrease for Genpact, moving from 0.9909% on June 10th to 0.9773% by June 12th. This specific reduction suggests AIVI’s algorithms may be weighing other fundamental factors or near-term indicators that temporarily overshadow the apparent value in this developed-international market stock, prompting a tactical adjustment within its periodically rebalanced ~100-stock portfolio. The action indicates the AI's continuous evaluation, even for stocks aligning with its core value mandate.

weight 0.991% → 0.977% (-0.014 pp)·stock up 8.9% in the 30 days before

Jun 12·entry $32.06·now $30.64

AIVI · Weight decrease · 2d

Genpact Ltd has experienced significant share price erosion, reporting a 27.9% decline over 90 days and currently trading at $32.95, which is 68% of its 52-week high. While the AIVI ETF's AI selection method targets developed-international value stocks, such sustained underperformance likely prompted a re-evaluation of the company's value proposition within its specific criteria. The AI overlay, assessing G's continued negative momentum including a 10.8% drop in the last 30 days, signaled a weakening investment case rather than a deeper value opportunity. This led to a consecutive weight decrease in AIVI, with G's allocation dropping from 0.9683% on May 11 to 0.9508% by May 13, and further to 0.9331% by June 1. For WisdomTree's AIVI fund, this systematic reduction suggests the AI determined that the Industrials sector stock no longer aligned with its dynamic international value parameters at this price level.

weight 0.956% → 0.933% (-0.022 pp)·stock down 0.9% in the 30 days before

Jun 1·entry $34.45·now $30.64

AIVI · Weight decrease · 2d

The AI ETF's consecutive weight decrease in Genpact likely reflects the algorithm's real-time assessment of deteriorating sentiment, weakening fundamentals, or increased risk factors for the company, prompting a strategic rebalancing away from the stock. For a retail investor, this trend signals potential emerging headwinds for Genpact or its sector, emphasizing the importance of independent research into company-specific news and market conditions before making investment decisions, rather than solely relying on ETF weighting changes.

weight 0.968% → 0.951% (-0.018 pp)·stock down 17.1% in the 30 days before

May 13·entry $29.44·now $30.64

AIVI · Weight decrease · 4d

The AI ETF likely initiated the consecutive weight decrease for Genpact (G) because its algorithms identified emerging negative trends in the company’s fundamentals, increased risk indicators, or a shift in sector outlook, prompting a systematic reduction in exposure. For a retail investor, this pattern signals a need for deeper due diligence into G's recent performance and sector dynamics, questioning whether their personal investment thesis still aligns with the AI’s risk-averse rebalancing.

weight 1.042% → 0.936% (-0.106 pp)·stock down 9.5% in the 30 days before

May 4·entry $34.14·now $30.64

AIVI · Weight decrease · 3d

The AI ETF likely initiated the consecutive weight decrease for Genpact due to algorithmic detection of deteriorating fundamental signals or a negative shift in its risk-reward profile, prompting a systematic reduction in exposure. The accelerated divestment on May 1st suggests the AI identified a more significant trigger or crossed a predefined risk threshold. For a retail investor, this systematic reduction by an AI signals a need to critically re-evaluate G's recent performance, company news, and broader sector outlook before making any investment decisions. It serves as an alert to conduct personal due diligence rather than an immediate sell signal.

weight 1.042% → 0.948% (-0.094 pp)·stock down 7.8% in the 30 days before

May 1·entry $34.33·now $30.64

AIVI · Weight decrease · 2d

The AI ETF's consecutive weight decrease in Genpact likely indicates its models have identified a sustained deterioration in the company's forward-looking fundamentals or a negative shift in its quantitative risk-reward profile. This persistent rebalancing suggests the AI is proactively reducing exposure based on ongoing signals of potential underperformance or increasing risk within the industrials sector. For retail investors, this trend should serve as a strong signal to conduct independent, deeper due diligence on Genpact, focusing on recent earnings, news, and sector-specific headwinds, rather than interpreting it as a direct buy or sell recommendation.

weight 1.042% → 1.030% (-0.013 pp)·stock down 6.7% in the 30 days before

Apr 30·entry $34.75·now $30.64